溢多利（300381.SZ）1月23日在投资者互动平台表示，公司R-PET酶目前已完成菌株构建及小试中试， 正在按照既定计划推进并持续进行重组菌株和酶的性能优化，同时探索废旧塑料的前处理工艺和降解工 艺。该产品将主要用于生物法降解废旧塑料和织物，重新回收作为再生料使用，可极大降低塑料污染， 有效减少碳足迹，在双碳背景下具有良好的市场前景。 每经AI快讯，有投资者在投资者互动平台提问：公司R-PET酶目前进展到什么阶段了？项目前景怎么 样？会成为公司未来主力产品吗？ （文章来源：每日经济新闻） ...

Core Viewpoint - The company Yiduoli (300381.SZ) is advancing its R-PET enzyme project, which aims to biologically degrade waste plastics and fabrics, thereby significantly reducing plastic pollution and carbon footprint in line with carbon neutrality goals [1] Group 1 - The R-PET enzyme has completed strain construction and small-scale testing, and is progressing according to the established plan [1] - The company is continuously optimizing the performance of recombinant strains and enzymes while exploring pre-treatment and degradation processes for waste plastics [1] - The product is expected to have a strong market outlook due to its potential to recycle waste materials into regenerated resources [1]

证券日报网讯1月14日，溢多利（300381）在互动平台回答投资者提问时表示，由于下游洗涤剂行业产 品种类较多，配方较为复杂，包括但不限于颗粒、粉剂、液体等剂型，功效包括去污、护理、防串色 等，所以洗涤酶产品研发和验证周期相对较长。公司洗涤酶产品自上市以来，持续与各类日化企业开展 合作与应用实验，逐步得到客户认可，实现国产替代。公司一直重视洗涤酶产品的研发和销售，不断加 大投入，优化营销队伍建设，丰富产品种类，从剂型到功效再到产品性能，都在逐步提升和完善。 ...

Core Viewpoint - The company announced the approval of the expected daily related transactions for 2026, which will not require shareholder meeting review [1] Group 1: Company Transactions - In the period from January to November 2025, the company sold products worth 8.0795 million yuan to Beidahuang Baoquanling Agricultural and Animal Husbandry Development Co., Ltd. and its subsidiaries, which is below the expected amount of 15 million yuan due to market conditions [1] - For 2026, the company anticipates sales of enzyme preparations and other products amounting to 15 million yuan, representing 1.23% of the same type of business [1] - The pricing for these transactions will be based on market prices, ensuring that the company's independence is not affected [1]

Core Viewpoint - Yiduoli (300381) reported an increase in sales and gross margin for its electroplating hydrogen peroxide enzyme product, which is primarily used in the cleaning process of electronic product manufacturing, although its overall revenue contribution remains small [1] Group 1 - The electroplating hydrogen peroxide enzyme is designed to remove hydrogen peroxide residues from material surfaces during the production of electronic products [1] - The product has been on the market since last year, and improvements in strain research and product performance have contributed to the increase in sales and gross margin in the first three quarters of this year compared to last year [1] - Despite the improvements, the overall revenue contribution of this product remains relatively low [1]

Group 1 - The Ministry of Industry and Information Technology (MIIT) has announced the first batch of 43 biomanufacturing pilot capacity building platforms, selected through recommendations from provincial authorities, expert evaluations, and public announcements [1] - Notable companies included in the list are Shandong Qilu Pharmaceutical Co., Ltd. (biopharmaceuticals), Shandong Longkete Enzyme Preparations Co., Ltd. (enzyme preparations), and Shandong University (food and additives, enzyme preparations) [1] - The MIIT aims to promote collaborative innovation across the industry chain by focusing on key product areas such as food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations [1] Group 2 - Platforms listed must concentrate on their respective service areas, increase resource investment, enhance hardware and software infrastructure, and improve professional talent training [1] - The MIIT will conduct annual evaluations of the platforms based on their hardware and software levels, the quantity and quality of pilot services provided, and will dynamically adjust the service capability ratings [1] - Platforms that fail to meet service capability and effectiveness requirements, or violate regulations related to intellectual property, safety production, environmental protection, and quality safety, will be removed from the list [1]

Core Viewpoint - Yidoli is actively enhancing its product offerings in the food enzyme sector through continuous research and development, aiming to improve strain performance and production processes while expanding its competitive edge in the food industry [2] Group 1: Product Offerings - The company’s food enzymes include high-temperature α-amylase, fungal α-amylase, pullulanase, xylanase, and glucose oxidase, which are widely used in industries such as starch sugar, alcohol, beverages, and baking [2] Group 2: Innovation and Market Demand - The company plans to strengthen application research and development in the food industry to launch new products that meet market demands, thereby further enhancing its product competitiveness [2]

Core Insights - The phytic acid enzyme market is experiencing significant growth, primarily driven by increased demand in the feed industry, especially after the ban on antibiotics in animal feed in China in 2020, positioning phytic acid enzymes as ideal alternatives [1][7] - China's annual production of phytic acid enzymes has significantly increased, from 43,200 tons in 2015 to an expected 120,600 tons by 2024, indicating a robust growth trajectory [1][8] - The global phytic acid enzyme market is projected to grow from $513 million in 2023 to $822 million by 2029, with a compound annual growth rate (CAGR) of 8.2% [6] Industry Overview - Phytic acid enzymes belong to the class of phosphoric monoester hydrolases and are crucial for enhancing the bioavailability of minerals in plant-based feeds by breaking down phytic acid [2] - The industry has evolved through three stages: initial development in the 1990s, rapid growth from 2001 to 2012, and a mature phase from 2013 onwards, with domestic products replacing imports and achieving international technical standards [3][4] Industry Chain - The upstream of the phytic acid enzyme industry includes raw materials such as wheat, barley, and microorganisms, while the downstream applications span food, pharmaceutical, and feed industries [5] - The feed industry is the largest application area for phytic acid enzymes, driven by the need to improve feed efficiency and reduce costs, with a notable increase in China's feed production reaching 250.7 million tons in the first nine months of 2025, up 6.4% year-on-year [5][6] Competitive Landscape - The global phytic acid enzyme market is highly competitive, with companies like Novozymes, DuPont, and DSM holding significant market shares due to their technological advantages and patent protections [8] - Chinese companies such as Blue Horizon Biotechnology, Yidali, and Xinghuo Technology are emerging as strong competitors, gradually capturing high-end market segments [8] Development Trends - Technological innovation is a key driver for the industry, with advancements in enzyme production and purification methods expected to enhance yield and efficiency [10] - The application of phytic acid enzymes is expanding beyond traditional uses in poultry and pig feed to include aquaculture and organic agriculture, indicating new growth opportunities [11] - Environmental sustainability is becoming increasingly important, with stricter regulations prompting phytic acid enzyme companies to enhance their eco-friendly practices and production processes [12]

Core Insights - The report focuses on the global market for food and beverage cellulase enzymes, analyzing market size, growth trends, and competitive landscape from 2020 to 2031 [2][3][4]. Market Overview - The global food and beverage cellulase enzyme market is segmented by product type and application, with projections for market size in 2020, 2024, and 2031 [3][4]. - The report highlights the overall development status of the food and beverage cellulase enzyme industry, including key characteristics and influencing factors [3][4]. Competitive Landscape - The report provides market share and rankings of major companies in the food and beverage cellulase enzyme sector based on sales volume and revenue for the years 2022 to 2025 [4][5]. - It includes a detailed analysis of the top five manufacturers' market shares in 2024 and their competitive positioning [5][6]. Regional Analysis - The report analyzes the supply and demand dynamics of food and beverage cellulase enzymes in major global regions, including North America, Europe, China, Japan, Southeast Asia, and India, with forecasts for production and revenue [5][6][7]. - It also examines the market size and growth rates for these regions from 2020 to 2031 [5][6]. Product and Application Segmentation - The report categorizes the food and beverage cellulase enzymes by product type and application, providing insights into sales volume and revenue trends [6][7]. - It forecasts the market share and growth rates for different product types and applications from 2020 to 2031 [6][7]. Industry Trends and Drivers - The report discusses the key trends and driving factors influencing the food and beverage cellulase enzyme industry, including technological advancements and regulatory impacts [8][9]. - It includes a SWOT analysis of Chinese companies in the sector, highlighting strengths, weaknesses, opportunities, and threats [8][9]. Supply Chain Analysis - The report outlines the supply chain dynamics of the food and beverage cellulase enzyme industry, including procurement and production models [9][10]. - It identifies key raw materials and their supply situation, as well as customer analysis across different applications [9][10].

Core Insights - The article discusses the first batch of bio-manufacturing landmark products announced by Hubei Province's Economic and Information Technology Department on October 9, highlighting significant advancements in the bio-manufacturing sector [2]. Group 1: Landmark Products - The first batch of landmark bio-manufacturing products includes: - Dongyang Sunshine: Thiocyanate Erythromycin - Tianji Bioenergy: Ultra-clean biodiesel - Bafeng Pharmaceutical: Amino acid raw materials - Xinhua Yang: Feed enzyme preparations - Guangji Pharmaceutical: High-quality riboflavin - China National Pharmaceutical Group: Inactivated vaccine for Porcine Circovirus Type 2 - Aibotai Bio: Research antibodies - Huisheng Biotechnology: Tylosin tartrate - Hite Bio-pharmaceutical: Injectable Epinephrine - Fuxing Biotechnology: Arachidonic acid (ARA) powder [2][3]. Group 2: Product Categories - The products are categorized into different types: - Scale Replacement Type: Thiocyanate Erythromycin, Ultra-clean biodiesel, Research antibodies, Tylosin tartrate - Key Improvement Type: Amino acid raw materials, Feed enzyme preparations, High-quality riboflavin, Arachidonic acid powder - Major Innovation Type: Inactivated vaccine for Porcine Circovirus Type 2, Injectable Epinephrine [3].